Shopping Cart
- Remove All
- Your shopping cart is currently empty
Fiztasovimab (NPC-21; EV2038), a fully human IgG1λ monoclonal antibody (mAb), targets human cytomegalovirus (hCMV). It exerts its neutralizing activity through binding to the antigenic domain 1 of glycoprotein B on the hCMV envelope, effectively inhibiting cell-to-cell transmission of hCMV [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $290 | 2-4 weeks | |
5 mg | $755 | 2-4 weeks | |
10 mg | $1,200 | 2-4 weeks |
Description | Fiztasovimab (NPC-21; EV2038), a fully human IgG1λ monoclonal antibody (mAb), targets human cytomegalovirus (hCMV). It exerts its neutralizing activity through binding to the antigenic domain 1 of glycoprotein B on the hCMV envelope, effectively inhibiting cell-to-cell transmission of hCMV [1]. |
Cas No. | 2467411-25-0 |
Storage | store at -80°C | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.